On average, safety net hospitals raised prices of oncology drugs 4.9 times their 340B purchased costs — and one breast cancer drug was hiked 11.3 percent — according to a September 2022 report from the Community Oncology Alliance.
Read the full post on Becker's Hospital Review - Healthcare News
